Orthofix Medical to Hold Analyst Teach-In Meeting on March 13, 2023

Rhea-AI Summary

Orthofix Medical Inc. (NASDAQ:OFIX) announced an Analyst Teach-In Meeting in Lewisville, TX, on March 13, 2023, from 2:30 to approximately 6:30 p.m. CT. The C-Suite management team will detail the product portfolio and commercial strategy following the merger with SeaSpine. The event has limited in-person attendance, but a live and archived webcast will be available on the company's investor page. The merged entity offers a broad range of products in biologics, spinal hardware, and orthopedic solutions, operating in around 68 countries globally, with a focus on innovation and education.

Positive

• Announcing an Analyst Teach-In Meeting indicates proactive investor engagement.
• The merged company covers a comprehensive portfolio in biologics and spinal solutions.
• Global distribution in approximately 68 countries enhances market reach.

Negative

• None.

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will host an Analyst Teach-In Meeting in Lewisville, TX on Monday, March 13, 2023 from 2:30 - approximately 6:30 p.m. CT.

The event will feature presentations from the C-Suite management team and business unit leaders describing the product portfolio of the newly merged Orthofix-SeaSpine organization, including addressable market opportunity and commercial strategy.

Due to limited capacity, in-person attendance is by invitation only. A live and archived webcast of the event will be available on the Investors page of the company’s website at ir.Orthofix.com.

About the Combined Company:

The newly merged Orthofix-SeaSpine organization is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.

The Company is headquartered in Lewisville, Texas and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany, Paris, France and Sao Paulo, Brazil.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230302005830/en/

Alexa Huerta

Investor Relations

Tel 214 937 3190

alexahuerta@orthofix.com

Denise Landry

Media Relations

Tel 214 937 2529

deniselandry@orthofix.com

Source: Orthofix Medical Inc.

FAQ

What is the purpose of the Orthofix analyst meeting on March 13, 2023?

The meeting aims to present the product portfolio and commercial strategy of the newly merged Orthofix-SeaSpine organization.

Where will the Orthofix Analyst Teach-In Meeting be held?

The meeting will take place in Lewisville, TX.

How can I watch the Orthofix meeting if I cannot attend in person?

A live and archived webcast of the meeting will be available on the company's investor page.

What products does the Orthofix-SeaSpine organization offer?

The combined company offers biologics, innovative spinal hardware, bone growth therapies, and specialized orthopedic solutions.

In how many countries does Orthofix operate?

Orthofix distributes its products in approximately 68 countries worldwide.